dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | García-Crespo, Carlos |
dc.contributor.author | Gallego, Isabel |
dc.contributor.author | Soria Benito, Maria Eugenia |
dc.contributor.author | de Ávila, Ana Isabel |
dc.contributor.author | Martínez-González, Brenda |
dc.contributor.author | Vázquez-Sirvent, Lucía |
dc.contributor.author | Quer Sivila, Josep |
dc.contributor.author | Gregori Font, Josep |
dc.date.accessioned | 2021-12-28T10:55:17Z |
dc.date.available | 2021-12-28T10:55:17Z |
dc.date.issued | 2021-04-03 |
dc.identifier.citation | García-Crespo C, Gallego I, Soria ME, de Ávila AI, Martínez-González B, Vázquez-Sirvent L, et al. Population Disequilibrium as Promoter of Adaptive Explorations in Hepatitis C Virus. Viruses. 2021 Apr 3;13(4):616. |
dc.identifier.issn | 1999-4915 |
dc.identifier.uri | https://hdl.handle.net/11351/6755 |
dc.description | Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Virus de l'hepatitis C; Vacunes universals |
dc.description.sponsorship | The work at CBMSO was supported by grants SAF2014-52400-R from Ministerio de Economía y Competitividad (MINECO), SAF2017-87846-R and BFU2017-91384-EXP from Ministerio de Ciencia, Innovación y Universidades (MCIU), PI18/00210 from Instituto de Salud Carlos III, S2013/ABI-2906 (PLATESA from Comunidad de Madrid/FEDER), and S2018/BAA-4370 (PLATESA2 from Comunidad de Madrid/FEDER). C.P. is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CPII19/00001), cofinanced by the European Regional Development Fund (ERDF). CIBERehd (Centro de Investigación en Red de Enfermedades Hepáticas y Digestivas) is funded by Instituto de Salud Carlos III. Institutional grants from the Fundación Ramón Areces and Banco Santander to the CBMSO are also acknowledged. The team at CBMSO belongs to the Global Virus Network (GVN). The work in Barcelona was supported by Instituto de Salud Carlos III, cofinanced by the European Regional Development Fund (ERDF) Grant No. PI19/00301 and by the Centro para el Desarrollo Tecnológico Industrial (CDTI) from the MICIU, Grant No. IDI-20200297. Work at CAB was supported by MINECO grant BIO2016-79618R and PID2019-104903RB-I00 (funded by the EU under the FEDER program) and by the Spanish State research agency (AEI) through project number MDM-2017-0737 Unidad de Excelencia “María de Maeztu”-Centro de Astrobiología (CSIC-INTA). C.G.-C. is supported by predoctoral contract PRE2018-083422 from MCIU. B.M.-G. is supported by predoctoral contract PFIS FI19/00119 from Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo), cofinanced by Fondo Social Europeo (FSE). |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Viruses;13(4) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Virus de l'hepatitis C |
dc.subject | Resistència als medicaments |
dc.subject | Virus - Reproducció |
dc.subject.mesh | Hepatitis C |
dc.subject.mesh | /virology |
dc.subject.mesh | Drug Resistance, Viral |
dc.subject.mesh | Virus Replication |
dc.title | Population Disequilibrium as Promoter of Adaptive Explorations in Hepatitis C Virus |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/v13040616 |
dc.subject.decs | hepatitis C |
dc.subject.decs | /virología |
dc.subject.decs | farmacorresistencia viral |
dc.subject.decs | replicación viral |
dc.relation.publishversion | https://doi.org/10.3390/v13040616 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [García-Crespo C, Ávila AI] Centro de Biología Molecular “Severo Ochoa” (CBMSO) (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, 28049 Madrid, Spain. [Gallego I] Centro de Biología Molecular “Severo Ochoa” (CBMSO) (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, 28049 Madrid, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, 28029 Madrid, Spain. [Soria ME] Centro de Biología Molecular “Severo Ochoa” (CBMSO) (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, 28049 Madrid, Spain. Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain. [Martínez-González B, Vázquez-Sirvent L] Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain. [Gregori J] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, 28029 Madrid, Spain. Unitat del Fetge, Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Roche Diagnostics, S.L., Sant Cugat del Vallés, 08174 Barcelona, Spain. [Quer J] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, 28029 Madrid, Spain. Unitat del Fetge, Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain |
dc.identifier.pmid | 33916702 |
dc.identifier.wos | 000643792700001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F00301 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |